Donepezil News and Research

RSS

Donepezil is a drug that is used to treat Alzheimer disease and is being studied in the treatment of side effects caused by radiation therapy to the brain. It is a type of cholinesterase inhibitor.

Brits unable to access Alzheimer's drugs

It appears that people in Britain suffering from Alzheimer's disease will be unlikely to benefit from the use of four drugs designed to treat the the degenerative brain disease.

16 Oct 2006

New 'patch' drug therapy for Alzheimer's has fewer side effects

Alzheimer's, is the most common form of dementia and affects as many as 15 million people worldwide.

20 Jul 2006

Donepezil slows brain shrinkage in some patients with mild cognitive impairment

According to a new study, the drug donepezil measurably slows the rate of brain shrinkage in some patients with mild cognitive impairment, a pre-Alzheimer's disease condition. The shrinkage was measured by magnetic resonance imaging (MRI).

18 Jul 2006

Donepezil (Aricept) helps cognitive function in brain tumor patients after radiation

A drug that is marketed to treat Alzheimer's disease also improves cognitive function, mood and quality of life in brain tumor patients following radiation therapy, according to a research team at Wake Forest University Baptist Medical Center.

21 Mar 2006

Donepezil for dementia due to Alzheimer's disease

Trials lasting up to 12 months show that taking daily doses of either 5mg or 10mg donepezil improves cognition and global clinical state in patients with Alzheimer's disease.

25 Jan 2006

Experimental drug works best in combination with older remedy for Alzheimer's disease and other dementias

An experimental drug combined with an already-popular memory-enhancing compound may further delay memory loss in patients with Alzheimer's disease and other dementias, Johns Hopkins University scientists, in collaboration with researchers from University of North Carolina, have found.

9 Jun 2005

Neurologists may have foot in the door to preventing Alzheimer’s before it starts

A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect -- though limited -- on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.

13 Apr 2005

Clinical diagnosis of Alzheimer's may be delayed

In a study of people with mild cognitive impairment (MCI), those who took the drug donepezil were at reduced risk of progressing to a diagnosis of Alzheimer's disease (AD) during the first year of the trial, but by the end of the 3-year study there was no benefit from the drug. Vitamin E was also tested in the study and was found to have no effect at any time point in the study when compared with placebo.

13 Apr 2005

Warning on Alzheimer drug mix up

Janssen Pharmaceutica, manufacturer of the Alzheimer drug galantamine (Reminyl), says it has learned of 10 cases in which individuals who should have gotten Reminyl accidentally received the diabetes drug glimepiride (Amaryl).

1 Nov 2004

Drinking regular cuppas could help improve your memory

Results of laboratory tests by a team from the University of Newcastle upon Tyne found that green and black tea inhibit the activity of certain enzymes in the brain which are associated with memory.

25 Oct 2004

Should medical knowledge be extended to enhance the lives of those who are already healthy?

This question and others are addressed in three articles about cosmetic neurology in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

28 Sep 2004

Study evaluated the ability of vitamin E and Aricept, to delay the progression of mild cognitive impairment to Alzheimer's disease

Researchers in the neurology department in the University of Arizona College of Medicine in Tucson participated in a study that evaluated the ability of vitamin E and donepezil hydrochloride, marketed as Aricept, to delay the progression of mild cognitive impairment to Alzheimer's disease.

2 Aug 2004

Donepezil may have short-term benefit for mild cognitive impairment

People with mild cognitive impairment (MCI) taking the drug donepezil were at reduced risk of progressing to Alzheimer's disease (AD) for the first 18 months of a 3-year study when compared with their counterparts on placebo

26 Jul 2004

Donepezil may have short-term benefit for mild cognitive impairment

21 Jul 2004

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

ARICEPT® a popular Alzheimer's drug has been shown to delay the onset of the disease among people with mild cognitive impairment.

19 Jul 2004

Drug slows the progression of mild cognitive impairment

For the first time, a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment, a memory disorder considered a strong early predictor of Alzheimer’s disease, to Alzheimer’s.

19 Jul 2004

People who have early stage Alzheimer's disease could be more capable of learning than previously thought

The promising studies suggest that some people with early cognitive impairment can still be taught to recall important information and to better perform daily tasks.

4 Jul 2004

Canadian Alzheimer Society responds to donepezil study

A study on the effects of donepezil on people with mild to moderate Alzheimer Disease entitled Long-term donepezil treatment in 565 patients with Alzheimer's Disease(AD2000): randomised double-blind trial appears in the June 26, 2004 issue of The Lancet.

29 Jun 2004

Most Alzheimer's drugs don't work

A new UK study published in THE LANCET concludes that the most widely used drugs to treat Alzheimer's disease have only minimal efficacy, and that an alternative approach for treatment is needed.

24 Jun 2004

Alzheimer’s drug has been shown to improve memory and cognition in multiple sclerosis (MS) patients

A drug widely used for treating dementia in Alzheimer’s patients has been shown to improve memory and cognition in multiple sclerosis (MS) patients who are mild to moderately cognitively impaired.

26 Apr 2004

Donepezil News and Research

Brits unable to access Alzheimer's drugs

New 'patch' drug therapy for Alzheimer's has fewer side effects

Donepezil slows brain shrinkage in some patients with mild cognitive impairment

Donepezil (Aricept) helps cognitive function in brain tumor patients after radiation

Donepezil for dementia due to Alzheimer's disease

Experimental drug works best in combination with older remedy for Alzheimer's disease and other dementias

Neurologists may have foot in the door to preventing Alzheimer’s before it starts

Clinical diagnosis of Alzheimer's may be delayed

Warning on Alzheimer drug mix up

Drinking regular cuppas could help improve your memory

Should medical knowledge be extended to enhance the lives of those who are already healthy?

Study evaluated the ability of vitamin E and Aricept, to delay the progression of mild cognitive impairment to Alzheimer's disease

Donepezil may have short-term benefit for mild cognitive impairment

Donepezil may have short-term benefit for mild cognitive impairment

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

Drug slows the progression of mild cognitive impairment

People who have early stage Alzheimer's disease could be more capable of learning than previously thought

Canadian Alzheimer Society responds to donepezil study

Most Alzheimer's drugs don't work

Alzheimer’s drug has been shown to improve memory and cognition in multiple sclerosis (MS) patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News